Cardinal Spine Receives FDA 510(k) Clearance for Cervical Vertebral Body Replacement

Cardinal Spine received FDA 510(k) clearance for the C-VBR cervical vertebral body replacement, reportedly the 2nd cervical VBR to be cleared by FDA and the 1st such device designed with no possibility of reduction in height after surgery.

Study of PEMF in Disc Degeneration

Study results suggest that use of pulsed electromagnetic field therapy, such as Orthofix’s Physio-Stim®, may reduce cellular inflammation and degredation in intervertebral disc cells.

Study Results: ReLeaf Catheter Supports Cost-effective Post-op Pain Management

Preliminary study results indicate that the Vital 5 ReLeaf Catheter improved pain scores and reduced post-op narcotic use following orthopaedic and spinal surgeries, and may support a transition to outpatient procedures.